Clin2
NCT07576660Possibly a fitRecruiting

Dexamethasone for lung injury from sepsis

Acute Respiratory Distress Syndrome (ARDS)

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,704 people
Ages
Any age
Study type
Interventional

Who can take part

  • You must be 18 years or older
  • You need to have a suspected or confirmed infection
  • You must be on a breathing machine or high-flow oxygen therapy
  • You need to have acute respiratory distress syndrome (ARDS) that started between 6 and 72 hours ago
  • You must not be pregnant or have certain conditions like severe COPD or heart failure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07395076Recruiting
Study of immune causes of acute respiratory distress

This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.

Paris
NCT07711964Recruiting· Phase 4
Finding the best steroid dose for ARDS patients on a ventilator

This trial tests different doses of corticosteroids to find the best one for people with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It aims to improve recovery while reducing side effects.

Taipei
NCT07052201Not yet recruiting· Phase 3
Dexamethasone for preventing lung disease in premature babies

This study tests whether a medicine called dexamethasone (a steroid) can help prevent a serious lung problem in very premature babies. It is for babies who still need a breathing machine after two weeks of life.

Hangzhou, Zhejiang
NCT07413094Recruiting· Phase 2
Testing a new drug for sepsis-related lung injury

This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.

Beijing
NCT07511582Recruiting· Phase 2
Steroids for severe breathing problems in the ICU

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Beijing, Beijing Municipality
NCT06269900Recruiting· Phase 3
Dexamethasone for Severe Hospital-Acquired Pneumonia with Inflammation

This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.

Amiens

Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.